International travel exposes millions to skin diseases acquired abroad, with dermatologic disorders ranking as the third most common health problem for returning travellers. Tropical and subtropical ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

Discover a study showing barzolvolimab rapidly improves chronic spontaneous urticaria symptoms, offering hope for patients ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.